Dedifferentiated liposarcoma lacks effective IGF-1→PPAR-γ adipogenic signaling due to epigenetic silencing of PPAR-γ2, with ...

Over the past decade, oncologists treating patients with advanced urothelial carcinoma (UC) and germ cell tumors (GCTs) have witnessed two extremes in drug development that evoke Dickens' opening line ...

Nearly 40% of new cancer cases worldwide are potentially preventable, according to one of the first investigations of its kind, which analysed dozens of cancer types in almost 200 countries. Cancer ...

Artemis 2 will use the SLS to send a crew of four aboard an Orion spacecraft on a 10-day mission looping within 4,600 miles (7,400 km) of the Moon. The crew consists of Commander Reid Wiseman, Pilot ...

1. In this cohort study, a novel prognostic model was developed to estimate prostate cancer-specific mortality (PCSM) while accounting for other-cause mortality (OCM). 2. This model more accurately ...

Regular physical activity — especially walking — may improve fatigue and boost quality of life for people with nonmetastatic colorectal cancer during the first 2 years after diagnosis, according to ...

GSK has committed $50 million in upfront capital and near-term milestones to secure a license to two cancer research foundation models from Noetik. San Francisco-based Noetik has used spatial biology ...

Z-endoxifen has demonstrated efficacy in phase 1 and 2 trials, improving progression-free survival and tumor response in metastatic breast cancer. The FDA's approval supports dose optimization and ...

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...

Common preservatives used to keep food safe and extend shelf life may be linked to a higher risk of several cancers and type 2 diabetes, according to two new studies from France. “These are very ...

Dec 29 (Reuters) - Genmab (GMAB.CO), opens new tab will stop development of its experimental antibody therapy to treat cancer that was in late-stage trials, the Danish drugmaker said on Monday. The ...

OpenAI on Thursday announced GPT-5.2, its most advanced artificial intelligence model. The company said the model is better at creating spreadsheets, building presentations, perceiving images, writing ...